In vitro chemoresponse analysis of cervical cancer patient specimens

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Perry W GrigsbyGiuseppe Del Priore

Abstract

The objective of this study was to report the results of in vitro chemoresponse analysis of primary, metastatic, and recurrent human cervical cancers. There were 557 tumor specimens submitted for testing from August 2006 to June 2010. Single agents tested were cisplatin, carboplatin, paclitaxel, docetaxel, epirubicin, fluorouracil, 4-hydroxy ifosfamide (active metabolite of ifosfamide), SN-38 (active metabolite of irinotecan), topotecan, and vinorelbine. Doublets tested were carboplatin/paclitaxel and cisplatin/topotecan. Tumor response was determined from dose-response curves. Results were scored as responsive, intermediate, or nonresponsive. Chemoresponse was reported as the combined responsive and intermediate results. Three hundred fifty-three (63.4%) of 557 submitted specimens were successfully assayed. Confirmation of histology and tumor status (primary, metastatic, or recurrent) was available for 273 specimens. The chemoresponse of the most active agents in primary cancers (n = 151) was 75% for SN-38, 71% for 4-hydroxy ifosfamide, 62% for topotecan, and 73% for carboplatin/paclitaxel. The chemoresponse of metastatic cancers (n = 66) was 54% for SN-38, 51% for 4-hydroxy ifosfamide, 44% for epirubicin, and 53% for carbopla...Continue Reading

References

Jan 1, 1991·Cancer Chemotherapy and Pharmacology·V Lira-PuertoF Muggia
Oct 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W P McGuireW T Creasman
Aug 1, 1985·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P BonomiF J Major
Mar 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W P McGuireG Photopulos
Jan 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G A OmuraB Anderson
Feb 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J A LacavaC T Vallejo
Feb 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C F VerschraegenJ J Kavanagh
Aug 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M E van der BurgJ B Vermorken
Mar 21, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M MorrisD M Gershenson
Apr 15, 1999·The New England Journal of Medicine·P G RoseS Insalaco
Mar 31, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C LhomméS Pecorelli
Mar 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J P CurtinR D Alvarez
Mar 10, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·N. R. Abu-RustumL. S. Massad
Dec 13, 2002·Gynecologic Oncology·Bradley J MonkJohn P Fruehauf
Oct 7, 2003·American Journal of Clinical Oncology·Carlos T VallejoBernardo A Leone
Feb 10, 2004·Gynecologic Oncology·Franco M MuggiaUNKNOWN Gynecologic Oncology Group study
Jul 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David H MooreThomas F Rocereto
May 25, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harry J LongUNKNOWN Gynecologic Oncology Group Study
Feb 1, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·H GallionB-U Sevin
Mar 24, 2007·International Journal of Clinical Oncology·Angeles Alvarez SecordAndrew Berchuck
Aug 1, 2007·Gynecologic and Obstetric Investigation·Michael L PearlD Scott McMeekin
Sep 1, 2007·American Journal of Clinical Oncology·Agustin A GarciaUNKNOWN Gynecologic Oncology Group Study
Jun 11, 2009·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Dimitrios PectasidesTheofanis Economopoulos
Sep 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bradley J MonkDavid Cella
Nov 26, 2009·Carcinogenesis·Michael J ThunElizabeth M Ward

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.